| - Industry | - Sector | Mr. Jesse F. Ledger CEO | NEO-L Exchange | CA67092F1045 ISIN |
| Canada Country | 101 Employees | 10 Jul 2026 Last Dividend | 7 Mar 2016 Last Split | - IPO Date |
Nuvo Pharmaceuticals Inc., operating under the brand name Miravo Healthcare, is a global provider of both prescription and non-prescription treatments targeting various medical conditions such as pain, allergy, neurology, and dermatology. The company is structured into three main segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. Established in 1983 and headquartered in Mississauga, Canada, the company was rebranded from Nuvo Research Inc. in March 2016. As of March 14, 2023, it functions as a subsidiary of Searchlight Pharma Inc.